Through literature reviews and key informant interviews, Genesis Analytics explored why individuals disengage from HIV and TB treatment, uncovering critical insights on policy gaps, administrative burdens, and stigma-related barriers. You can view the final report here

Genesis Analytics, in collaboration with Euro Health Group (EHG), will conduct quantitative secondary data analysis of existing internal and external Global Fund (GF) datasets to identify key data, drivers and barriers related to the Funding Request and Grant-Making (FR-GM) stages for Grant Cycle 7 (GC7). Each dataset will be assessed for its utility, relevance, completeness and quality.

As a partner in the South to South Learning Network’s (SSLN) insight 2 implementation (i2i) project, Genesis is key to efforts to use the best available evidence to inform and improve HIV prevention policies and practices in 15 African countries.

Genesis has been contracted by the Bill & Melinda Gates Foundation and is working with the Population Council to synthesise and contextualise evidence to guide countries in managing and implementing comprehensive HIV prevention responses for AGYW.

Wellcome contracted Genesis Analytics to provide a landscape mapping and analysis of important South African actors in health research, funding, interventions and advocacy to inform Wellcome’s South African policy strategy.

Genesis Analytics partnered with PATH to explore the acceptability, programmatic fit and usability of microarray patches (MAPs) as an alternative delivery mechanism for HIV pre-exposure prophylaxis (PrEP) and multipurpose prevention technologies (MPTs) in South Africa.

Genesis was contracted by the Bill and Melinda Gates Foundation to consolidate the implementation challenges and promising practices of AGYW HIV prevention programmes in South Africa.

Genesis was contracted by the Bill & Melinda Gates Foundation to assist in providing support to the assessment of PEPFAR’s DREAMS and the Global Fund’s mentoring component of their adolescent girls and young women’s HIV prevention programmes.

Genesis has been contracted by the Bill & Melinda Gates Foundation to synthesise and contextualise evidence to guide countries in managing and implementing comprehensive HIV prevention responses for adolescent girls and young women (AGYW).

Genesis Analytics, on behalf of the Bill & Melinda Gates Foundation, conducted a qualitative landscape analysis of the policy and implementation environment for community-based services in South Africa to inform the sustainable planning and implementation of their investments.

Genesis has been contracted by the International Planned Parenthood Federation (IPPF) to conduct the second round of client exit interviews (CEIs) for family planning clients in 17 countries in Africa and Asia through the WISH2 project.

Genesis was contracted by UNAIDS to lead a transition readiness assessment (TRA) in Sri Lanka and develop an implementable sustainability roadmap to mitigate for transition risks and vulnerabilities.

MenConnect is an innovative approach to supporting HIV treatment initiation and adherence among men living with HIV in South Africa. Genesis was responsible for crafting behaviourally informed messages that are timed to the treatment journey milestones and tailored per psychographic segment.

Genesis Analytics was contracted by the Bill & Melinda Gates Foundation to develop a tool that could help countries to define the performance of their HIV programmes against a global standardised set of programmatic components.

Genesis was appointed by the Bill & Melinda Gates Foundation to work with key country stakeholders to consolidate and synthesise research findings and review the implementation of best practices of adolescent girls and young women HIV prevention programmes in South Africa.

Genesis Analytics was contracted by the Bill & Melinda Gates Foundation to document the extent to which research with male sexual partners (MSPs) had been undertaken as part of the DREAMS programme, the methods used, and the use of results to inform programming in 10 high-burden countries in sub-Saharan Africa.

Genesis has been contracted by the National Institute for Communicable Diseases (NICD) to conduct a cross-sectional survey of healthcare utilisation and seroprevalence during the Covid-19 pandemic in three provinces in South Africa.

Genesis supported the Cipla Foundation in an innovative solution to expand the footprint of Centralised Chronic Medicines Dispensing Distribution (CCMDD) locations as a solution for chronic patients to pick up their medicines from decentralised locations.

At the start of the Covid-19 epidemic in South Africa, Genesis Analytics developed a useful tool for looking at and understanding the impact of the epidemic on the healthcare system.

Genesis, in partnership with the University of Manitoba, is implementing the South to South HIV Prevention Learning Network (SSLN), which supports peer learning in a network structure to improve HIV prevention programming in 15 African countries.

Merck contracted Genesis to develop programme key performance indicators (KPIs) and an M&E framework to efficiently monitor correct tablet distribution and use at country and community levels of its anti-bilharzia drug Praziquantel (PZQ). Merck has provided nearly one billion PZQ tablets to the World Health Organisation (WHO), which then distributes these to countries for mass drug administration in endemic areas.

Genesis was contracted to assist Population Services International (PSI) and Society for Family Health (SFH) to develop PSI’s South Africa strategy.

Genesis undertook the evaluation of the Phase 1 implementation of the government’s policy of National Health Insurance (NHI) in South Africa. The main aim was to assess whether the NHI Phase 1 interventions had achieved their objective of health system strengthening in primary health care facilities.

Genesis Analytics supported the Department of Basic Education (DBE) to investigate the understanding, accessibility and acceptability of providing sexual and reproductive health (SRH) services to boys and girls attending school in South Africa.

Genesis was contracted to conduct a rapid impact assessment of the Choice for Change (C4C) family planning programme in Kenya targeting adolescent girls. Choice for Change is a CIFF-funded initiative, though implemented through Marie Stopes Kenya (MSK), IPAS and the United Nations Population Fund (UNFPA).

Genesis Analytics was part of a consortium that developed a communication strategy targeting tuberculosis and related illnesses affecting mineworkers, ex-mineworkers, their families and communities in Southern Africa.

The National Economic and Development Labour Council (Nedlac) commissioned Genesis Analytics to conduct an urgent independent study on the likely economic, health and social impacts of some of the amendments proposed in the Liquor Amendment Bill, 2017.

South Africans (18-34 years) who are exposed to the Testa Boy campaign are 50% more likely to agree that men who test for HIV are strong and responsible, according to a study done by Genesis Analytics for the Centre for Communication Impact.

Genesis was contracted to do a baseline and follow-up evaluation of the Healthy Living Alliance (HEALA) campaign “Are you drinking yourself sick?”, which was aimed at reducing sugary-drinks consumption and promoting support for the sugar tax. 

Genesis was employed by the International Partnership for Microbicides to test eight potential brand names and then the packaging for a monthly vaginal ring that helps to prevent new HIV infections in women.

UNAIDS contracted Genesis to support the meeting of 19 South African municipalities to implement its 90-90-90 project that assists countries to control the HIV epidemic by setting ambitious targets to get people on antiretroviral (ARV) treatment and ensure they are virally suppressed.

Genesis was asked by Soul City to evaluate their Soul Buddyz HIV-prevention campaign in schools from 2004. We used social media, as well as direct approaches, to track down Soul Buddyz members for the study.

The HIV prevention field is changing rapidly as treatment becomes widely available and as new prevention technologies reach the market. The BMGF commits significant funding to healthcare and HIV, and needs to decide whether its strategic focus areas are appropriate in this changing landscape.

There are many HIV communication campaigns running in South Africa and many have overlapping objectives. However, funders need to know whether these campaigns are working, in which areas they are working, and what to continue with and what to stop or change.